Cullinan Oncology Inc
NASDAQ:CGEM
Cullinan Oncology Inc
NASDAQ:CGEM
Price:
23.03 USD
-4.56%
Market Closed
Updated:
May 29, 2024
Cullinan Oncology Inc
Net Change in Cash
|
Cullinan Oncology Inc
Net Change in Cash Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
Net Change in Cash
-$57.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Change in Cash
$11.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Change in Cash
-$218m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Change in Cash
-$21.9B
|
CAGR 3-Years
-140%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Change in Cash
-$126.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Change in Cash
-$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cullinan Oncology Inc's Net Change in Cash?
Net Change in Cash
-57.7m
USD
-57.7m
USD
Based on the financial report for Dec 31, 2023, Cullinan Oncology Inc's Net Change in Cash amounts to -57.7m USD.
What is Cullinan Oncology Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-33%
-33%
You don't have any saved screeners yet
